Researchers tackle rare, aggressive tumors in children
- OPACC
- Jan 27
- 1 min read
Recently, CureSearch for Children’s Cancer, a privately funded organization, recognized the work of John Prensner, M.D., Ph.D., a pediatric neuro-oncologist at University of Michigan Health C.S. Mott Children’s Hospital and assistant professor of pediatrics and biological chemistry at Michigan Medicine, with their 2025 Young Investigator Award. Here, Prensner answers questions about ATRT and how researchers are working to improve our understanding of the disease
Recent Posts
See AllA team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
While the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...
The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type...
Comments